Considering the different TNF inhibitors agents used by our sample, our study demonstrated that a greater number of cases of TB were associated with ADA than with ETN, Finally, we found that newer drugs such as CZP, which have had a much shorter postmarketing surveillance period for assessment of their potential for infectious adverse events, appear to be associated with a higher frequency of incident TB. This evidence concerns the gene ADA and tuberculosis.